Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melissa Peet

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Behavioural Pharmacology|December 9, 2014
Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female miceMichael D Berquist, M Melissa Peet, Lisa E Baker
Pharmaceutics|March 28, 2024
Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV PreventionM Melissa Peet, Vivek Agrahari, Meredith R Clark, et al.
Pharmaceutics|December 11, 2014
Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 PreventionMeredith R Clark, M Melissa Peet, Sarah Davis, et al.
Advanced Drug Delivery Reviews|May 1, 2024
Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approachesTanvi Karve, Amruta Dandekar, Vivek Agrahari, et al.
Journal of Neurosurgery. Pediatrics|May 2, 2012
Chemotherapy administration directly into the fourth ventricle in a nonhuman primate modelDavid I Sandberg, M Melissa Peet, Mark D Johnson, et al.
Pharmaceutics|March 26, 2022
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast CancerDeepal Vora, Amruta Dandekar, Sonalika Bhattaccharjee, et al.
AAPS Pharmscitech|May 6, 2026
Formulation Development of Topical Inserts Containing Doxycycline and Doxycycline Combined with Tenofovir Alafenamide and Elvitegravir for the Prevention of Sexually Transmitted InfectionsVivek Agrahari, M Melissa Peet, Jasmin Monpara, et al.
Expert Opinion on Drug Delivery|October 17, 2022
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challengesVivek Agrahari, Sharon M Anderson, M Melissa Peet, et al.
Pharmaceutics|August 4, 2019
Topical Inserts: A Versatile Delivery Form for HIV PreventionM Melissa Peet, Vivek Agrahari, Sharon M Anderson, et al.
International Journal of Pharmaceutics|April 22, 2020
Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless ratsYing Jiang, Xinyi Gao, Onkar N Singh, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Behavioural Pharmacology|December 9, 2014
Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female miceMichael D Berquist, M Melissa Peet, Lisa E Baker
Pharmaceutics|March 28, 2024
Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV PreventionM Melissa Peet, Vivek Agrahari, Meredith R Clark, et al.
Pharmaceutics|December 11, 2014
Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 PreventionMeredith R Clark, M Melissa Peet, Sarah Davis, et al.
Advanced Drug Delivery Reviews|May 1, 2024
Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approachesTanvi Karve, Amruta Dandekar, Vivek Agrahari, et al.
Journal of Neurosurgery. Pediatrics|May 2, 2012
Chemotherapy administration directly into the fourth ventricle in a nonhuman primate modelDavid I Sandberg, M Melissa Peet, Mark D Johnson, et al.
Pharmaceutics|March 26, 2022
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast CancerDeepal Vora, Amruta Dandekar, Sonalika Bhattaccharjee, et al.
AAPS Pharmscitech|May 6, 2026
Formulation Development of Topical Inserts Containing Doxycycline and Doxycycline Combined with Tenofovir Alafenamide and Elvitegravir for the Prevention of Sexually Transmitted InfectionsVivek Agrahari, M Melissa Peet, Jasmin Monpara, et al.
Expert Opinion on Drug Delivery|October 17, 2022
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challengesVivek Agrahari, Sharon M Anderson, M Melissa Peet, et al.
Pharmaceutics|August 4, 2019
Topical Inserts: A Versatile Delivery Form for HIV PreventionM Melissa Peet, Vivek Agrahari, Sharon M Anderson, et al.
International Journal of Pharmaceutics|April 22, 2020
Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless ratsYing Jiang, Xinyi Gao, Onkar N Singh, et al.
Pageof 3